Datavault AI Inc. Form 8-K Summary
Business Context and Reporting Period
Company: Datavault AI Inc. (Delaware corporation, NASDAQ: DVLT)
Reporting Date: March 31, 2025
Event: Entry into a Material Definitive Agreement (Securities Purchase Agreement) for a registered direct offering and concurrent private placement.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than operational financial results. Key transaction metrics include:
- Total Debt Principal: $16,666,666 (comprising $5,555,555 Initial Notes and $11,111,111 Additional Notes).
- Total Cash Proceeds: $15,000,000 ($5,000,000 for Initial Notes and $10,000,000 for Additional Notes).
- Original Issue Discount (OID): 10% on the Notes.
- Warrants Issued: Rights to purchase up to 19,346,101 shares of Common Stock (6,448,700 Initial Warrants; 12,897,401 Additional Warrants).
- Warrant Exercise Price: $0.8615 per share.
- Placement Agent Fees: 8.0% of gross proceeds plus up to $15,000 in expense reimbursement.
- Liquidity Impact: Proceeds intended to fund operations; specific cash balance or liquidity ratios are not disclosed in this filing.
Material Changes and Terms
The transaction introduces significant new debt and potential equity dilution with the following terms:
- Debt Structure: Senior secured convertible notes maturing 18 months from issuance. No interest accrues unless an event of default occurs (then 12% per annum).
- Conversion Terms:
- Initial Conversion Price: $1.00 per share.
- Alternate Conversion Price: Greater of the Floor Price ($0.1794) or 90% of the 10-day VWAP.
- Make-Whole Provision: If the Alternate Conversion Price falls below the Floor Price, the principal amount of the Notes is increased to compensate holders.
- Redemption Obligation: The Company must use up to 30% of proceeds from future financings to redeem Notes at 105% of principal.
- Security Interest: Notes are secured by a security interest in all Company assets and guaranteed by domestic subsidiaries.
- Lock-Up: 45-day lock-up period on the sale of Common Stock or equivalents post-closing.
Guidance, Outlook, and Risks
Closing Timeline:
- Initial Closing: Expected on or about April 1, 2025, subject to customary conditions.
- Additional Closing: Expected 20 days after mailing a definitive information statement (Schedule 14(c)) for stockholder approval of the issuance of shares upon conversion and warrant exercise.
- Dilution: Significant potential dilution from the conversion of notes and exercise of warrants, subject to beneficial ownership limitations (4.99%/9.99%).
- Future Financing Restrictions: Mandatory use of future financing proceeds for debt redemption and a 18-month right of first refusal for Purchasers to participate in subsequent financings (up to 65%).
- Variable Rate Transaction: Restrictions on issuing certain securities that would constitute a Variable Rate Transaction until Notes are no longer held.
- Stockholder Approval: The Additional Closing is contingent on stockholder approval of the issuance of shares issuable upon conversion and a one-time reset of exercise prices for certain existing warrants.
Investor Verification Checklist
- Verify the status of the Stockholder Approval required for the Additional Closing and the issuance of Conversion Shares.
- Confirm the exact closing dates for the Initial and Additional Closings.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific negative covenants and default triggers.
- Assess the impact of the 30% mandatory redemption provision on future capital raising capabilities.
- Monitor the Company's cash position post-closing to evaluate liquidity runway given the new debt obligations.